Oncology medicine spending at list prices vs Cell and gene therapy venture capital and public funding deal count
Oncology medicine spending at list prices and Cell and gene therapy venture capital and public funding deal count worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Oncology medicine spending at list prices
Unit: billion USD · 2 observations
Forecast: dashed line, hollow markers, shaded band
Cell and gene therapy venture capital and public funding deal count
Unit: count · 3 observations
Provenance
Where these numbers come from
Oncology medicine spending at list prices
Total spending on cancer medicines valued at list prices.
2 observations in Global · source organisations: IQVIA
Cell and gene therapy venture capital and public funding deal count
Number of venture capital and public funding transactions for cell and gene therapies in a given year.
3 observations in Global · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring